Streetbeat News

Products Services

ADIL

Adial Pharmaceuticals (NASDAQ:ADIL) announced the completion of dosing in the pharmacokinetics study of AD04 for Alcohol Use Disorder. The study's topline results are expected in Q4 2024, marking a significant milestone towards initiating Phase 3 clinical trials.

Portfolio Pulse from Vandana Singh

August 07, 2024 | 12:30 pm

JNVR

Janover Inc (NASDAQ: JNVR) announced that its subsidiary Groundbreaker Tech Inc achieved a 64% profit margin in June 2024, marking its second consecutive month of profitability. This reflects a significant increase in operating margins from 30% to 64% since its acquisition in November 2023. Despite this positive news, JNVR stock closed 6.84% lower at $0.5700 on Tuesday.

Portfolio Pulse from Anusuya Lahiri

August 07, 2024 | 12:30 pm

ADIL

Adial Pharmaceuticals has announced that it expects to release topline results during the fourth quarter.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 12:30 pm

ADIL

Adial Pharmaceuticals announced the completion of the last patient dose in its pharmacokinetics study of AD04, a treatment for Alcohol Use Disorder.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 12:30 pm

GH

Guardant Health announced the results of the COSMOS study, published in Clinical Cancer Research. The study, the largest to date evaluating tissue-free MRD detection, shows 81% sensitivity for recurrence in stage II or higher colon cancer. The Guardant Reveal test demonstrated high sensitivity and specificity in predicting colorectal cancer recurrence, highlighting the clinical utility of ctDNA for rapid evaluation without prior tissue analysis.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 12:24 pm

IONQ

IonQ has announced a breakthrough in partial error correction for quantum computing, which enhances the efficiency of running large applications on near-term quantum systems.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 12:20 pm

AMD

HPE

SLNH

Soluna Holdings has announced several key updates: reserving 512 H100 SXM GPUs with HPE for AI workloads, closing $30M funding for Project Dorothy 2 expansion, raising an additional $1.25M for Soluna Cloud, and partnering with HPE to deliver sustainable enterprise AI. CEO John Belizaire will also attend an HPE and AMD executive panel and speak at the 2024 Ai4 Conference.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 12:19 pm

ADTX

Aditxt's subsidiary, Pearsanta, has submitted a proposal for a Clinical Trial Translational Endpoints Research Award to the Congressionally Directed Medical Research Programs of the Department of Defense.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 12:17 pm

HPE

Hewlett Packard Enterprise (HPE) has expanded its AI-powered networking portfolio by introducing behavioral analytics-based network detection and response capabilities through HPE Aruba Networking Central. This enhancement aims to improve security policy enforcement in both cloud and local area networks using Zero Trust Network Access.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 12:17 pm

LXRX

Lexicon Pharmaceuticals will present three posters at the 2024 Annual Conference of the Association of Diabetes Care & Education Specialists, taking place from August 9-12 in New Orleans.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 12:16 pm